Table of Contents
Cover Article An ObGyn’s guide to aromatase inhibitors
as adjuvant therapy for breast cancer
Q&A with Andrew M. Kaunitz, MD; Janelle Yates
Hear Dr. Kaunitz describe bone-protective strategies for patients on AI therapy
Skilled US imaging of the adnexae
Part 2 of 4: The non-neoplastic ovarian mass
Ilan E. Timor-Tritsch, MD; Steven R. Goldstein, MD
READ THE SERIES
Editorial A new (to the US) first-line agent for heavy menstrual bleeding
Robert L. Barbieri, MD
Update Update: pelvic floor dysfunction
Cindy L. Amundsen, MD
Examining The Evidence At what thickness is the endometrial stripe cause for concern
in a woman who has postmenopausal bleeding?
Linda R. Duska, MD
Web Exclusives Why you should recommend flu vaccine to "every single patient" AAGL: Laparoscopic or vaginal hysterectomy preferred New study reveals a link between estrogen-progestin HRT and advanced breast cancer Sex practices driving surge in HPV-linked oral cancer The patient-centered medical home: Is it a win-all or lose-all proposition for ObGyns? Twitter 101 for ObGyns: Pearls, pitfalls, and potential
Comment & Controversy Cost is a deterrent to IUD use...Want to increase IUD use? Remove the financial risk
Medical Verdicts Large prolapsed fibroid left untreated—despite surgery ...
DIGITAL EDITION
Subscribe to OBG Management e-alert
Back to top
|
